Kundakovic M. Sex-specific Epigenetics: Implications for Environmental Studies of Brain and Behavior. Curr Environ Health Rep. In Press.
Kundakovic M and Jaric I (2017). The Epigenetic Link between Prenatal Adverse Environments and Neurodevelopmental Disorders. Genes 8, 104.
Kundakovic M (2017). Fearing the Mother's Virus: The Lasting Consequences of Prenatal Immune Activation on the Epigenome and Brain Function. Biol Psychiatry. 81(3):e23-e25.
Kundakovic M, Jiang Y, Kavanagh D, Dincer A, Brown L, Pothula V, Zharovsky E, Park R, Jacobov R, Magro I, Kassim B, Wiseman J, Dang K, Sieberts SK, Roussos P, Fromer M, Harris B, Lipska BK, Peters MA, Sklar P, and Akbarian S (2017). Practical Guidelines for High-resolution Epigenomic Profiling of Nucleosomal Histones in Postmortem Human Brain Tissue. Biol Psychiatry 81(2):162-170.
Peter CJ*, Fischer LK*, Kundakovic M*, Garg P*, Jakovcevski M, Dincer A, Amaral AC., Ginns EI, Galdzicka M, Bryce CP, Ratner C, Waber DP, Mokler D, Medford G, Champagne FA, Rosene DL, McGaughy JA, Sharp AJ, Galler JR, Akbarian S (2016). DNA methylation signatures of early childhood malnutrition associated with impairments in attention and cognition. Biol Psychiatry 80(10):765-774.
Nestler EJ, Pena CJ, Kundakovic M, Mitchell A, and Akbarian S (2016). Epigenetic basis of mental illness. Neuroscientist 22(5):447-63.
The PsychENCODE Consortium, Akbarian S, Liu C, ..., Kundakovic M, ..., Senthil G, Lehner T, Sklar P, Sestan N (2015). The PsychENCODE Project. Nat Neurosci. 18(12):1707-1712.
Braithwaite EC, Kundakovic M, Ramchandani PG, Murphy SM, and Champagne FA (2015). Maternal prenatal depressive symptoms predict infant NRC31 1F and BDNF IV DNA methylation. Epigenetics. 10(5):408-17.
Kundakovic M, Gudsnuk K, Herbstman JB, Tang D, Perera FP, Champagne FA (2015). DNA methylation of BDNF as a biomarker of early life adversity. Proc Natl Acad Sci U S A. 112(22):6807-13.
Kundakovic M and Champagne FA (2015) Early Life Experience, Epigenetics, and the Developing Brain. Neuropsychopharmacology 40(1):141-53.
Kundakovic M (2014) Postnatal risk environments, epigenetics, and psychosis: putting the pieces together. Soc Psychiatry Psychiatr Epidemiol. 49(10):1535-6.
Kundakovic M, Lim S, Gudsnuk K, Champagne FA (2013) Sex-specific and strain-dependent effects of early life adversity on behavioral and epigenetic outcomes. Front Psychiatry 4:78.
Kundakovic M, Gudsnuk K, Franks B, Madrid J, Miller RL, Perera FP, Champagne FA (2013) Sex- specific epigenetic disruption and behavioral changes following low-dose in utero bisphenol A exposure. Proc Natl Acad Sci U S A 110(24): 9956-61.
Kirkbride JB, Susser E, Kundakovic M, Kresovich JK, Davey Smith G, and Relton CL (2012) Testing epigenetic factors as mediating prenatal nutritional influences on schizophrenia risk. Epigenomics 4: 303-15.
Kundakovic M and Champagne FA (2011) Epigenetic perspective on the developmental effects of bisphenol A. Brain, Behavior, and Immunity 25: 1084-93.
Grayson DR, Kundakovic M, and Sharma RP (2010) Is there a future for histone deacetylase inhibitors in the pharmacotherapy of psychiatric disorders? Mol Pharmacol 77: 126-35.
Kundakovic M, Chen Y, Guidotti A, and Grayson DR (2009) The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes. Mol Pharmacol 75: 342-54.
Guidotti A, Dong E, Kundakovic M, Satta R, Grayson DR, and Costa E (2009) Characterization of the action of antipsychotic subtypes on valproate-induced chromatin remodeling. Trends Pharmacol Sci 30:55-60.
Kundakovic M, Chen Y, Costa E, Grayson DRH. (2007) DNA Methyltransferase Inhibitors Coordinately Induce Expression of the Human Reelin and Glutamic Acid Decarboxylase 67 Genes. Mol Pharmacol 71: 644-53.
Grayson DR, Chen Y, Costa E, Dong E, Guidotti A, Kundakovic M, Sharma RP.H (2006) The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (+/-) in schizophrenia. Pharmacol Ther 111:272-86.
Mitchell CP, Chen Y, Kundakovic M, Costa E, Grayson DRH (2005) Histone deacetylase inhibitors decrease reelin promoter methylation in vitro. J Neurochem 93:483-92.
Kundakovic M (2016). Epigenetics of Psychiatric Disorders. In Tollefsbol (ed) Medical Epigenetics. Elsevier. p 335-350.
Kundakovic M, Peter C, Roussos P, and Akbarian S (2016). Epigenetic approaches towards the molecular and genetic risk architectures of schizophrenia. In Abel (ed) The Neurobiology of Schizophrenia. Elsevier. p 61-82.
Kundakovic M (2016). In utero Bisphenol A exposure and epigenetic programming of neurobehavioral outcomes. In Hollar D (ed), Epigenetics, the Environment, and Children's Health across Lifespans. Springer. p 67-92.
Kundakovic M (2014). DNA Methyltransferase Inhibitors and Psychiatric Disorders, In Peedicayil J, Avramopoulos D, and Grayson D (eds), Epigenetics in Psychiatry. Elsevier, pp 497-514.